微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 67.84% | 34.1% | 7.2% | 26/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 63.28% | 26.13% | 17.76% | 45/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 53.74% | 6.17% | 3.57% | 64/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 51.89% | 5.78% | 2.56% | 73/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 50.59% | -0.78% | 0.83% | 76/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 50.17% | 3.42% | -0.87% | 72/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 50.62% | -2.03% | 3.19% | 76/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 49.05% | -8.84% | -3.8% | 78/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 50.99% | -2.68% | 5.1% | 74/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 48.51% | -10.3% | -6.11% | 77/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 51.67% | -18.96% | -3.98% | 72/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 53.81% | -17.02% | 2.7% | 69/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 52.39% | -17.59% | -3.12% | 71/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 54.08% | -15.04% | -15.17% | 68/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 63.75% | 2.99% | -1.68% | 45/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 64.84% | 5.69% | 1.98% | 41/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 63.58% | 7.01% | -0.13% | 49/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 63.66% | 8.16% | 2.84% | 49/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 61.9% | -7.07% | 0.9% | 58/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 61.35% | -3.86% | 3.25% | 57/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 59.42% | -7.61% | 0.95% | 63/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 58.86% | -1.01% | -11.64% | 60/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 66.61% | 1.32% | 4.38% | 50/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 63.81% | -0.92% | -0.78% | 44/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 64.31% | 0.16% | 8.17% | 50/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 59.45% | -8.76% | -9.57% | 41/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 65.74% | 8.86% | 2.08% | 49/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 64.4% | 4.72% | 0.31% | 29/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 64.21% | 8.11% | -1.46% | 36/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 65.16% | 17.33% | 7.89% | 20/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 60.39% | -3.58% | -1.8% | 54/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 61.5% | -6.6% | 3.55% | 22/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 59.39% | -13.25% | 6.94% | 27/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 55.53% | -14.9% | -11.34% | 23/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 62.63% | -17.06% | -4.88% | 46/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 65.85% | -12.43% | -3.82% | 18/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 68.46% | -9.73% | 4.91% | 18/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 65.25% | -14.19% | -13.59% | 16/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 75.52% | 3.31% | 0.43% | 18/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 75.2% | 3.53% | -0.85% | 5/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 75.84% | 6.32% | -0.26% | 8/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 76.04% | 5.96% | 4.03% | 3/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |